Andere Sprachen Evolent Health, Inc.

Aktien

A14UCN

US30050B1017

EVH

Markt geschlossen - Nyse Andere Börsenplätze 22:00:01 18.04.2024			% 5 Tage	% 1. Jan.
29.62 ^USD	-0.07%		-2.98%	-10.32%

28.03.	EVOLENT HEALTH, INC. : Canaccord Genuity gibt eine Kauf-Bewertung ab	ZM
15.03.	EVOLENT HEALTH, INC. : JPMorgan Chase bekräftigt seine Kaufempfehlung	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	18.04.
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22.02.
Evolent Health: Q4 Earnings Snapshot	22.02.
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22.02.
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22.02.
Evolent Announces Fourth Quarter and Full Year 2023 Results	22.02.
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22.02.
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22.02.
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14.02.
Evolent Health, Inc. Announces Board Changes	14.02.
Evolent to Release Fourth Quarter 2023 Financial Results on Thursday, February 22, 2024	25.01.
Evolent Health, Inc. Announces Pricing of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	06.12.
Evolent Health Plans $350 Million Convertible Senior Notes Offering; Shares Fall	05.12.
Evolent Health Shares Drop on $350 Million Note Offering	05.12.
Evolent Health, Inc. Announces Proposed Offering of $350.0 Million of Convertible Senior Notes Due 2029 to Pay Down Senior Term Loan	05.12.
Evolent Health : INDEPENDENT AUDITORS’ REPORT - Form 8-K	03.11.
Evolent Health: Q3 Earnings Snapshot	02.11.
Earnings Flash (EVH) EVOLENT HEALTH Posts Q3 EPS $0.30	02.11.
Earnings Flash (EVH) EVOLENT HEALTH Reports Q3 Revenue $511M, vs. Street Est of $509.8M	02.11.
Evolent Announces Third Quarter 2023 Results	02.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evolent Health, Inc.

Aktien

A14UCN

US30050B1017

EVH

Andere Sprachen

Filter